Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CureVac (CVAC) Liabilities and Shareholders Equity (2019 - 2025)

Historic Liabilities and Shareholders Equity for CureVac (CVAC) over the last 7 years, with Q3 2025 value amounting to $1.3 billion.

  • CureVac's Liabilities and Shareholders Equity rose 4189.62% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 billion, marking a year-over-year increase of 1956.9%. This contributed to the annual value of $857.9 million for FY2024, which is 115.42% up from last year.
  • CureVac's Liabilities and Shareholders Equity amounted to $1.3 billion in Q3 2025, which was up 4189.62% from $779.8 million recorded in Q2 2025.
  • CureVac's 5-year Liabilities and Shareholders Equity high stood at $2.2 billion for Q2 2021, and its period low was $599.6 million during Q2 2024.
  • Its 5-year average for Liabilities and Shareholders Equity is $1.1 billion, with a median of $928.1 million in 2022.
  • Per our database at Business Quant, CureVac's Liabilities and Shareholders Equity surged by 16420927.79% in 2021 and then tumbled by 5445.24% in 2022.
  • Over the past 5 years, CureVac's Liabilities and Shareholders Equity (Quarter) stood at $1.3 billion in 2021, then crashed by 33.74% to $877.9 million in 2022, then fell by 3.39% to $848.1 million in 2023, then grew by 1.15% to $857.9 million in 2024, then soared by 55.16% to $1.3 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $1.3 billion for Q3 2025, versus $779.8 million for Q2 2025 and $780.8 million for Q1 2025.